OptimizeRx (NASDAQ:OPRX – Get Free Report) announced that its Board of Directors has approved a share buyback program on Thursday, March 5th, RTT News reports. The company plans to repurchase $10.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.8% of its shares through open market purchases. Shares repurchase [...]
OptimizeRx (NASDAQ:OPRX) to Repurchase $10.00 million in Outstanding Stock
